Dec. 2, 2014, 9:43 AM
- In a all-stock transaction, Imprimis Pharmaceuticals (IMMY) acquires South Coast Specialty Compounding. As part of the transaction, Park signs a license agreement allowing it to immediately begin making and dispensing Imprimis' ophthalmology and urology formulations in the 13 states where it is currently licensed, including CA, NV, OR and HI.
- Park will generate almost $4M in top line revenue in 2014.
- Imprimis acquired its first pharmacy, Pharmacy Creations, LLC, in April 2014.
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and... More
Country: United States
Other News & PR